[go: up one dir, main page]

MX173359B - Procedimiento para la preparacion de compuestos de carbapenem en forma cristalina y producto obtenido - Google Patents

Procedimiento para la preparacion de compuestos de carbapenem en forma cristalina y producto obtenido

Info

Publication number
MX173359B
MX173359B MX753487A MX753487A MX173359B MX 173359 B MX173359 B MX 173359B MX 753487 A MX753487 A MX 753487A MX 753487 A MX753487 A MX 753487A MX 173359 B MX173359 B MX 173359B
Authority
MX
Mexico
Prior art keywords
procedure
preparation
product obtained
crystalline form
carbapenem compounds
Prior art date
Application number
MX753487A
Other languages
English (en)
Other versions
MX7534A (es
Inventor
Haruki Matsumura
Tetsuo Noguchi
Yukio Oxaki
Makoto Sunagawa
Yutaka Isobe
Yutaka Takeuchi
Original Assignee
Sumitomo Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Pharma filed Critical Sumitomo Pharma
Publication of MX7534A publication Critical patent/MX7534A/es
Publication of MX173359B publication Critical patent/MX173359B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX753487A 1986-07-30 1987-07-30 Procedimiento para la preparacion de compuestos de carbapenem en forma cristalina y producto obtenido MX173359B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP17932186 1986-07-30
JP15776987 1987-06-26

Publications (2)

Publication Number Publication Date
MX7534A MX7534A (es) 1993-10-01
MX173359B true MX173359B (es) 1994-02-23

Family

ID=26485103

Family Applications (1)

Application Number Title Priority Date Filing Date
MX753487A MX173359B (es) 1986-07-30 1987-07-30 Procedimiento para la preparacion de compuestos de carbapenem en forma cristalina y producto obtenido

Country Status (20)

Country Link
US (1) US4888344A (es)
EP (1) EP0256377B1 (es)
JP (1) JP2665767B2 (es)
AR (1) AR243189A1 (es)
AU (1) AU596857B2 (es)
CA (1) CA1322371C (es)
DE (1) DE3781980T2 (es)
DK (1) DK172666B1 (es)
ES (1) ES2052524T3 (es)
FI (1) FI88037C (es)
GR (1) GR3006254T3 (es)
HK (1) HK169595A (es)
HU (1) HU199473B (es)
IE (1) IE60588B1 (es)
IL (1) IL83372A (es)
LU (1) LU88635I2 (es)
MX (1) MX173359B (es)
NO (2) NO165543C (es)
NZ (1) NZ221224A (es)
PH (1) PH24710A (es)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1283906C (en) * 1983-05-09 1991-05-07 Makoto Sunagawa .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF
KR880006244A (ko) * 1986-11-24 1988-07-22 후지사와 도모 기찌 로 3-피롤리디닐티오-1-아자바이스클로[3.2.0]햅트2-엔-2-카르복실산 화합물 및 이의 제조방법
DE69019610D1 (de) * 1989-07-06 1995-06-29 Banyu Pharma Co Ltd Cyclische Derivate des Amidinylthiocarbapenems.
US5112818A (en) * 1989-12-29 1992-05-12 Banyu Pharmaceutical Co., Ltd. 2-(2-cyclopropylpyrrolidin-4-ylthio)carbapenhem derivatives
TW264475B (es) * 1991-09-20 1995-12-01 Takeda Pharm Industry Co Ltd
JP2696807B2 (ja) * 1992-08-06 1998-01-14 田辺製薬株式会社 カルバペネム誘導体の製法
GB9503717D0 (en) * 1995-02-24 1995-04-12 Smithkline Beecham Plc Novel compounds
FR2735474B1 (fr) * 1995-06-13 1997-08-08 Roussel Uclaf Chlorhydrate de zilpaterol sous une forme cristallisee particuliere, son procede de preparation et les produits intermediaires mis en oeuvre
KR100530478B1 (ko) * 1997-02-07 2005-11-23 교토 야쿠힝 고교 가부시키가이샤 카르바페넴 화합물, 이의 용도 및 이의 중간체 화합물
WO1999057121A1 (fr) 1998-05-01 1999-11-11 Kyoto Pharmaceutical Industries, Ltd. Derives de carbapenem, son utilisation et composes intermediaires a base de carbapenem
EP1182204B1 (en) * 1999-06-03 2004-04-07 Eisai Co., Ltd. Crystals of carbapenem derivatives and pharmaceutical preparations for injection
TWI250160B (en) * 1999-07-06 2006-03-01 Sankyo Co Crystalline 1-methylcarbapenem compound
US7041660B2 (en) 1999-07-06 2006-05-09 Sankyo Company, Limited Crystalline 1-methylcarbapenem derivatives
ATE352300T1 (de) * 2000-05-12 2007-02-15 Novalar Pharmaceuticals Inc Zusammensetzung bestehend aus phentolaminmesylat und deren verwendung
JP5079190B2 (ja) * 2001-04-27 2012-11-21 大日本住友製薬株式会社 アゼチジノン誘導体およびその製造方法
US20040176350A1 (en) * 2001-05-21 2004-09-09 Hiroshi Matsui Carbapenem compound
KR100451672B1 (ko) * 2001-06-05 2004-10-08 한미약품 주식회사 결정성 세프디니르 산부가염, 이의 제조방법 및 이를이용한 세프디니르의 제조방법
WO2003016312A1 (fr) * 2001-08-13 2003-02-27 Eisai Co., Ltd. Procede de preparation d'antibiotiques a base de carbapenem
CA2457642C (en) 2001-09-26 2009-01-06 Merck & Co., Inc. Crystalline forms of ertapenem sodium
CN100387599C (zh) * 2001-09-26 2008-05-14 麦克公司 用于生产碳青霉烯化合物的方法
ITMI20012364A1 (it) * 2001-11-09 2003-05-09 Antibioticos Spa Processo di sintesi della cefixima via alchil-o arilsolfonati
JP4625637B2 (ja) 2002-02-22 2011-02-02 シャイア エルエルシー 活性物質送達系及び活性物質を保護し投与する方法
US20030236306A1 (en) * 2002-06-20 2003-12-25 Chen Andrew X. Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof
US7229630B2 (en) * 2002-06-20 2007-06-12 Novalar Pharmaceuticals, Inc. Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof
EP1541174A4 (en) 2002-09-11 2005-09-14 Michio Ishibashi MEDICINE OR COSMETIC PRODUCT
ES2370829T3 (es) * 2004-06-02 2011-12-23 Sandoz Ag Producto intermedio de meropenem en forma cristalina.
WO2006035300A2 (en) * 2004-09-30 2006-04-06 Ranbaxy Laboratories Limited A process for the preparation of meropenem
JP4547245B2 (ja) * 2004-12-16 2010-09-22 株式会社パーマケム・アジア ペリンドプリルエルブミンのｉ型結晶、及びその製造方法
US20110039943A1 (en) * 2005-03-14 2011-02-17 Robert Alonso Methods for treating skin disorders with topical nitrogen mustard compositions
US7872050B2 (en) * 2005-03-14 2011-01-18 Yaupon Therapeutics Inc. Stabilized compositions of volatile alkylating agents and methods of using thereof
US8501818B2 (en) * 2005-03-14 2013-08-06 Ceptaris Therapeutics, Inc. Stabilized compositions of alkylating agents and methods of using same
US20070197781A1 (en) * 2005-07-29 2007-08-23 Neera Tewari Processes for the preparation of carbapenems
SI1926732T1 (sl) 2005-09-05 2014-02-28 Ranbaxy Laboratories Limited Postopek za pripravo karbapenskih spojin
JP5247449B2 (ja) * 2005-09-15 2013-07-24 オーキッド ケミカルズ アンド ファーマシューティカルズ リミテッド β−ラクタム系抗生物質の改善された調製方法
CN100497338C (zh) * 2006-01-05 2009-06-10 上海医药工业研究院 4－甲基－7－氧－1－氮杂双环[3.2.0]庚－2－烯－2－羧酸类衍生物的制备方法
KR100781821B1 (ko) * 2006-02-16 2007-12-03 문순구 카르바페넴계 화합물의 제조방법
KR20090007375A (ko) * 2006-03-28 2009-01-16 카네카 코포레이션 카르바페넴 화합물의 개량된 제조 방법
WO2007125788A1 (ja) * 2006-04-28 2007-11-08 Kaneka Corporation カルバペネム抗生物質中間体の改良された晶析方法
WO2009075309A1 (ja) * 2007-12-12 2009-06-18 Dainippon Sumitomo Pharma Co., Ltd. 製剤組成物
US20090216010A1 (en) * 2008-02-22 2009-08-27 Wei-Hong Tseng Crystalline carbapenem compound and produced method thereof
EP2098525A1 (en) 2008-02-26 2009-09-09 Savior Lifetec Corporation Crystalline carbapenem compound and produced method thereof
CN107149591A (zh) * 2008-03-27 2017-09-12 埃科特莱茵药品有限公司 烷基化剂的稳定组合物及其使用方法
US8097719B2 (en) * 2008-07-15 2012-01-17 Genesen Labs Meropenem intermediate in novel crystalline form and a method of manufacture of meropenem
KR20110049823A (ko) * 2008-07-30 2011-05-12 랜박시 래보러터리스 리미티드 카르바페넴 화합물의 제조 방법
MX2011009532A (es) * 2009-03-13 2011-10-24 Daewoong Bio Inc Metodo mejorado para preparar meropenem usando polvo de zinc.
WO2011048583A1 (en) 2009-10-23 2011-04-28 Ranbaxy Laboratories Limited Process for the preparation of carbapenem compounds
WO2011141847A1 (en) * 2010-05-10 2011-11-17 Orchid Chemicals And Pharmaceuticals Limited An improved process for the preparation of meropenem
AU2011319478A1 (en) 2010-10-22 2013-05-23 Sun Pharmaceutical Industries Limited A process for the preparation of pure meropenem trihydrate
CN101962383A (zh) * 2010-11-12 2011-02-02 上海巴迪生物医药科技有限公司 一种美罗培南的合成方法
WO2012081033A2 (en) * 2010-12-06 2012-06-21 Sequent Scientific Limited A process for preparation of imipenem
CN102532140B (zh) * 2010-12-21 2015-03-11 北大方正集团有限公司 一种美罗培南三水合物的制备方法
CN102250096B (zh) * 2011-09-05 2016-04-06 江西华邦药业有限公司 一种美罗培南的制备方法
CN103570718B (zh) * 2012-07-31 2016-06-29 深圳市海滨制药有限公司 一种美罗培南原料药、其制备方法及包含其的药物组合物
CN103570719B (zh) * 2012-07-31 2016-03-02 深圳市海滨制药有限公司 一种美罗培南原料药、其制备方法及包含其的药物组合物
CN103570720B (zh) * 2012-07-31 2016-02-10 新乡海滨药业有限公司 一种美罗培南原料药、其制备方法及包含其的药物组合物
KR101331762B1 (ko) 2012-12-28 2013-11-20 주식회사 대웅제약 메로페넴의 삼수화물의 제조방법
CN103044429B (zh) * 2013-01-28 2015-04-01 苏州二叶制药有限公司 一种美罗培南的制备方法
WO2014121028A1 (en) 2013-02-01 2014-08-07 Ocularis Pharma, Llc Methods and compositions for daily ophthalmic administration of phentolamine to improve visual performance
US9795560B2 (en) 2013-02-01 2017-10-24 Ocularis Pharma, Llc Aqueous ophthalmic solutions of phentolamine and medical uses thereof
KR102144777B1 (ko) 2013-06-19 2020-08-18 제이더블유중외제약 주식회사 결정형 메로페넴 삼수화물의 제조방법
EP3122749B1 (en) 2014-03-27 2019-03-13 Johnson Matthey Public Limited Company Process for preparing a carbapenem antibiotic
AU2019360953A1 (en) 2018-10-15 2021-05-13 Ocuphire Pharma, Inc. Methods and compositions for treatment of glaucoma and related conditions
WO2020087021A1 (en) 2018-10-26 2020-04-30 Ocuphire Pharma, Inc. Methods and compositions for treatment of presbyopia, mydriasis, and other ocular disorders
CN115368310A (zh) 2021-05-18 2022-11-22 奥库菲尔医药公司 合成甲磺酸酚妥拉明的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK153486C (da) * 1978-07-03 1988-11-28 Merck & Co Inc Analogifremgangsmaade til fremstilling af krystallinsk n-formimidoyl-thienamycin-monohydrat
EP0113101A1 (en) * 1982-12-30 1984-07-11 Merck & Co. Inc. 6-(1-Hydroxyethyl)-2-SR8-1-methyl-1-carbadethiapen-2-em-3-carboxylic acid esters
JPS60104088A (ja) * 1983-11-11 1985-06-08 Sumitomo Chem Co Ltd 新規なβ−ラクタム化合物およびその製造法
CA1283906C (en) * 1983-05-09 1991-05-07 Makoto Sunagawa .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF
US4748238A (en) * 1984-03-14 1988-05-31 Merck & Co., Inc. Crystalline 1R,5S,6S,8R-1-methyl-2-(N,N-dimethylcarbamimidoylmethylthio)-6-(1-hydroxyethyl)-1-carbapen-2-em-3-carboxylic acid
US4713451A (en) * 1984-04-09 1987-12-15 Merck & Co., Inc. Crystalline dimethyliminothienamycin
US4761408A (en) * 1984-11-02 1988-08-02 Ciba-Geigy Corporation Crystalline aminomethyl compound
NZ214691A (en) * 1984-12-27 1988-08-30 Sumitomo Pharma The preparation of carbapenem derivatives and beta-lactam intermediates
US4788282A (en) * 1985-06-07 1988-11-29 Bristol-Myers Company Deprotection of allylic esters and ethers

Also Published As

Publication number Publication date
EP0256377B1 (en) 1992-09-30
FI873299A0 (fi) 1987-07-29
FI88037B (fi) 1992-12-15
IL83372A0 (en) 1987-12-31
FI873299A (fi) 1988-01-31
DE3781980D1 (de) 1992-11-05
DK399087D0 (da) 1987-07-30
AU7619687A (en) 1988-03-03
IL83372A (en) 1992-05-25
NO165543C (no) 1991-02-27
JP2665767B2 (ja) 1997-10-22
AR243189A1 (es) 1993-07-30
NO165543B (no) 1990-11-19
NO873205D0 (no) 1987-07-30
AU596857B2 (en) 1990-05-17
IE871959L (en) 1988-01-30
CA1322371C (en) 1993-09-21
NZ221224A (en) 1989-10-27
HUT44553A (en) 1988-03-28
HU199473B (en) 1990-02-28
US4888344A (en) 1989-12-19
LU88635I2 (fr) 1995-12-01
HK169595A (en) 1995-11-10
ES2052524T3 (es) 1994-07-16
FI88037C (fi) 1993-03-25
EP0256377A1 (en) 1988-02-24
GR3006254T3 (es) 1993-06-21
DE3781980T2 (de) 1993-02-18
NO873205L (no) 1988-02-01
DK399087A (da) 1988-01-31
MX7534A (es) 1993-10-01
JPS6434986A (en) 1989-02-06
NO1997013I1 (no) 1997-10-17
DK172666B1 (da) 1999-05-10
PH24710A (en) 1990-10-01
IE60588B1 (en) 1994-07-27

Similar Documents

Publication Publication Date Title
MX173359B (es) Procedimiento para la preparacion de compuestos de carbapenem en forma cristalina y producto obtenido
MX174238B (es) Procedimiento para la preparacion de derivados de pirimidina y producto obtenido
MX14331A (es) Procedimiento para preparar derivados de adenosinaprocedimiento para preparar derivados de adenosina y producto obtenido y producto obtenido
MX13836A (es) Procedimiento para producir derivados de 5'-deoxi-5-fluorocitidina y producto obtenido,
MX5220A (es) Procedimiento para la produccion de derivados de dicloroanilina y producto obtenido
PT88541A (pt) Processo para a preparacao de composicoes sob a forma de gel contendo factores de crescimento
EP0336205A3 (en) Process for the preparation of isocyanuratepolyisocyanates, the compounds obtained according to this process and their use
MX14221A (es) Procedimiento para la preparacion de 3-/2-(dimetilamino)etil/-n-metil-1-(fenilmetil)-1h-indol-5-metano-sulf oamida y producto obtenido
ES2024036B3 (es) Procedimiento para fabricacion de producto abrasivo termoestable compuesto
IT8647723A0 (it) Procedimento per la fabbricazione di articoli in poliesteri parzialmente cristallini
MX9205455A (es) Procedimiento para la preparacion de diritromicina cristalina
MX9260A (es) Procedimiento de preparacion de nuevos derivados de 1-bencenosulfonil-2-oxo-5-alcoxipirrolidina y producto obtenido
MX10537A (es) Procedimiento para la preparacion de sales de adicion de acidos cefem cristalizadas y producto resultante
MX9217A (es) Procedimiento para la preparacion de derivados de aminoacido y producto resultante
MX11493A (es) Procedimiento para la preparacion de derivados de pirimidina y producto obtenido.
MX14431A (es) Procedimiento para preparar 3-carbonil-1-aminoalquil-1h-indoles y producto obtenido
MX17107A (es) Procedimiento para la preparacion de tiazolo-(1,5)-benzodiazepinas y producto obtenido
MX12881A (es) Procedimiento para la preparacion de acidos 4-oxo-3-quinolincarboxilicos y producto obtenido
MX21871A (es) Procedimiento para la preparacion de oxadiazolil fenoxialquilisoxazoles y compuestos resultantes
ES2022952B3 (es) Proceso para la preparacion de naftacenos
MX9173A (es) Procedimiento para la preparacion de compuestos anionicos ciclo-diilidicos y producto obtenido.
MX6263A (es) Procedimiento para la preparacion de derivados sustituidos de benzamida y producto obtenido
MX11704A (es) Procedimiento para la preparacion de nuevos derivados de 1-aril-sulfonil-2-oxo-5-alcoxi-pirrolidina y producto obtenido
AR240799A1 (es) Procedimiento para producir derivados de 9-carbamoilfluoreno y producto obtenido.
MX10085A (es) Procedimiento para la preparacion de 4-arilcarbonil-1-((4-morfolinil)-alquilo-inferior)-1h-indoles y producto obtenido.